Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001321543-06-000170
Filing Date
2006-04-18
Accepted
2006-04-18 16:35:44
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10KSB FOR DECEMBER 31, 2005 maindoc.htm 10-K/A 2542798
2 EXECUTIVE EMPLOYMENT AGREEMENT ex10-23.htm EX-10.23 77035
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23.htm EX-23 4347
4 CERTIFICATION ex31-1.htm EX-31.1 11103
5 CERTIFICATION ex31-2.htm EX-31.2 11160
6 CERTIFICATION ex32-1.htm EX-32.1 6605
7 CERTIFICATION ex32-2.htm EX-32.2 6636
  Complete submission text file 0001321543-06-000170.txt   2661214
Mailing Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170 2126729190
CALLISTO PHARMACEUTICALS INC (Filer) CIK: 0001142380 (see all company filings)

EIN.: 651107840 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32325 | Film No.: 06765038
SIC: 2834 Pharmaceutical Preparations